5 Am Venture Management, LLC Portfolio Holdings

5 Am Venture Management, LLC

  • $251 Million
  • Q3 2024

5 Am Venture Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $251 Million distributed in 28 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Entrada Therapeutics, Inc. with a value of $70.5M, Tyra Biosciences, Inc. with a value of $22.1M, Centessa Pharmaceuticals PLC with a value of $20.5M, Celldex Therapeutics, Inc. with a value of $16.9M, and Viridian Therapeutics, Inc.\De with a value of $16.8M.

Examining the 13F form we can see an increase of $37.2M in the current position value, from $214M to 251M.

5 Am Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about 5 Am Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $251 Million
Healthcare: $251 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 28
  • Current Value $251 Million
  • Prior Value $214 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email